Cresco Labs is trading 10.57% up now at $0.71 after second-quarter revenue increased to $173.34 million.
- Results were reported before the August 6, 2026 market open, with net income reaching $15.37 million.
- Adjusted EBITDA declined year over year to $39.54 million from $40.88 million.
- Operating income also fell, creating a mixed earnings picture despite the strong live-session gain.